Uveal Melanoma Market

1

• Uveal Melanoma - Market Insights, Epidemiology,
  Market Forecast 2027

DelveInsight 2018 All rights reserved
2
Introduction Uveal Melanoma
As the tumor enlarges, it may cause distortion of
the pupil (iris melanoma), blurred vision
(Ciliary body melanoma), or markedly decreased
visual acuity caused by secondary retinal
detachment (choroidal melanoma).
DelveInsight 2018 All rights reserved
3
Misdiagnoses occur in less than 4 of enucleated
eyes at tertiary referral centers.
The diagnostic error rate in the
Collaborative Ocular Melanoma Study (COMS) was
only 0.48.
DIAGNOSIS
The diagnostic error rate in the COMS, however,
was measured under ideal conditions all tumors
were well visualized and photographed.
In real-world situations, the misdiagnosis rate
for posterior melanoma may be greater than that
reported by the Collaborative Ocular
Melanoma Study
DelveInsight 2018 All rights reserved
4
Aspects Covered in the Report
The report covers the descriptive overview of
Uveal Melanoma explaining its pathophysiology,
disease classification, diagnostic approaches and
treatment algorithm
The report provides the understanding of the
future competition in Uveal Melanoma by reviewing
the market drivers and barriers
05
01
04
02
The report also reviews the detailed historical
and forecasted Uveal Melanoma market size
covering the drug outreach in 7MM
The report provides the insight into the
epidemiology of the disease and its treatment in
the 7 MM
03
The report is a comprehensive account of both the
current and emerging therapies covering the
impact of the new therapies on the current
treatment landscape
DelveInsight 2018 All rights reserved
5
Emerging Drugs And Companies
DelveInsight 2018 All rights reserved
6
Market Insight
Despite of Uveal Melanomas effective primary
therapy, nearly 50 of patients develop
metastatic disease.
Several palliative treatments for UM offered in
the US and Europe include Liverdirected
treatments- Trans arterial Catheter and
Immunotherapy, targeted therapy.
Despite usual success in achieving local control,
outcomes for patients with metastatic disease
remains impoverished. h
As per National Cancer Institute, the mean
age-adjusted incidence of Uveal melanoma in the
United States is approximately xxx new cases per
million people, with no clear variation by
latitude
DelveInsight 2018 All rights reserved
7
Complete Information

• For complete information please click below
• Or
• write to us at
• info_at_delveinsight.com

Click here
DelveInsight 2018 All rights reserved
8
About Delveinsight
DelveInsight 2018 All rights reserved
9
Services Offered at DelveInsight
DelveInsight 2018 All rights reserved
10
Contact Us info_at_delveinsight.com 91-11-4568
9769 www.delveinsight.com blog/delveInsight/
twitter/delveInsight LinkedIn/delveInsight
DelveInsight 2018 All rights reserved